Tell us about your search experience on the TGA website - complete our short survey
AusPAR: Gemtuzumab ozogamicin
Australian Public Assessment Report
Device/Product Name
Mylotarg
Active ingredients
Gemtuzumab ozogamicin
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-01426-1-6
Submission Type
New biological entity
Decision
Approved